MRPL46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.038800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.072200E-01
Normal-vs-Stage2
6.148600E-01
Normal-vs-Stage3
1.772630E-01
Normal-vs-Stage4
1.539390E-01
Stage1-vs-Stage2
2.199200E-01
Stage1-vs-Stage3
1.168000E-01
Stage1-vs-Stage4
1.890220E-01
Stage2-vs-Stage3
1.296590E-01
Stage2-vs-Stage4
5.121200E-01
Stage3-vs-Stage4
4.949400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.394600E-01
Normal-vs-AfricanAmerican
2.854600E-01
Normal-vs-Asian
8.931000E-01
Caucasian-vs-AfricanAmerican
5.589200E-01
Caucasian-vs-Asian
7.397800E-01
AfricanAmerican-vs-Asian
4.801800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.044200E-01
Normal-vs-Female
8.259800E-01
Male-vs-Female
2.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.043600E-01
Normal-vs-Age(41-60Yrs)
6.615000E-01
Normal-vs-Age(61-80Yrs)
5.694400E-01
Normal-vs-Age(81-100Yrs)
6.607400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.486800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.273600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.804200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.193200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.935500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.084100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.987800E-01
Normal-vs-Daily Drinker
8.730800E-01
Normal-vs-Weekly Drinker
6.931800E-01
Normal-vs-Occasional Drinker
8.002000E-01
Normal-vs-Social Drinker
4.812400E-01
Non Drinker-vs-Daily Drinker
3.299400E-01
Non Drinker-vs-Weekly Drinker
7.054800E-01
Non Drinker-vs-Occasional Drinker
4.103200E-01
Non Drinker-vs-Social Drinker
9.441800E-01
Daily Drinker-vs-Weekly Drinker
6.731200E-01
Daily Drinker-vs-Occasional Drinker
8.961200E-01
Daily Drinker-vs-Social Drinker
4.384200E-01
Weekly Drinker-vs-Occasional Drinker
7.534800E-01
Weekly Drinker-vs-Social Drinker
7.766200E-01
Occasional Drinker-vs-Social Drinker
4.977000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.982400E-01
Normal-vs-Grade 2
8.931000E-01
Normal-vs-Grade 3
9.490200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.455800E-01
Grade 1-vs-Grade 3
7.179400E-01
Grade 1-vs-Grade 4
7.982400E-01
Grade 2-vs-Grade 3
2.522600E-01
Grade 2-vs-Grade 4
8.931000E-01
Grade 3-vs-Grade 4
9.490200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.074600E-01
Normal-vs-NonDiabetic
8.688600E-01
Diabetic-vs-NonDiabetic
8.563900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.444400E-01
Normal-vs-NoPancreatitis
7.403000E-01
Pancreatitis-vs-NoPancreatitis
3.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.081000E-01
Normal-vs-N1
6.192800E-01
N0-vs-N1
3.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.205200E-01
Normal-vs-TP53-NonMutant
8.871000E-01
TP53-Mutant-vs-TP53-NonMutant
4.172000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
